What is Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd's (688336.SS) StockRank?

MoatMap's StockRank for Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS) is 79/100, with a Buy signal. This is a composite score combining Quality (75), Value (41), and Momentum (50) factor ranks across MoatMap's 19,000+ stock universe.

Does Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd have an economic moat?

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS) has a Quality factor score of 75/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd a buy, hold, or sell?

MoatMap's current signal for Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS) is Buy, based on a StockRank of 79/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd in?

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS) operates in the Healthcare sector, specifically the Biotechnology industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

688336.SS

BUYREMOVE

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd · Healthcare · China · $5.9B · Avg Vol: $50M/d

StockRank

P/E (TTM)

11.7x

ROE

41.8%

D/E

—

Dividend %

0.8%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Sunshine Guojian is a Chinese biopharmaceutical firm focused on antibody drugs. While it has decent quality metrics, it is primarily a drug developer rather than a global CDMO gatekeeper, exposing it to high clinical trial and domestic regulatory risks.

COMPANY DESCRIPTION

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. focuses on the development, manufacturing, and commercialization of antibody therapeutics, with a strong presence in autoimmune and oncology treatments. Its flagship product, Yisaipu, was China's first marketed recombinant human TNF-alpha receptor fusion protein, establishing a strong first-mover advantage. The company is a vertically integrated biopharmaceutical leader with one of the largest antibody production capacities in China.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	122M	150M	176M	621M	72.0%
EPS	0.01	0.07	0.17	0.69	288.7%
Shares	617M	617M	617M	617M	0.0%
Debt	22M	7M	7M	80M	53.5%
Equity	681M	724M	823M	1.2B	22.4%
Op CF	35M	62M	42M	450M	135.3%
Inv CF	-135M	-71M	-111M	-468M	—
Fin CF	22M	-15M	-8M	-16M	—

PRICE (1M)-24.6%

SMA 50SMA 200

$8.15

RSI (14)

37.0

52W High

$14.28

From 52W High

0.6%

SCORE BREAKDOWN

Quality

ROIC

39.0%98.4

ROE

41.8%96.5

GP/Assets

44.6%82.4

Op. Margin

44.0%97.2

FCF/Assets

-7.1%32.4

Piotroski

—55.8

Int. Cover

50.0x91.4

D/E Ratio

—N/A

Current Ratio

21.99x96.2

Value

P/E (TTM)

11.7x84.5

EV/EBITDA

9.8x42.5

P/FCF

—N/A

P/B

4.0x29.7

P/S

8.0x30.2

Div Yield

0.8%22.8

Momentum

52W High %

57%35.0

RS 6M

-22%53.1

SMA 50/200

1.12x82.4

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

-75%6.1

Q Growth

73%82.2

FUNDAMENTALS

Market Cap

$5.9B

P/E (Forward)

46.4x

Gross Margin

92.1%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 688336.SS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
688336.SS	Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd(you)	$5.9B	79	BUY
002821.SZ	Asymchem Laboratories (Tianjin) Co., Ltd.	$6.3B	80	BUY
002007.SZ	Hualan Biological Engineering Inc.	$3.7B	78	BUY
688578.SS	Shanghai Allist Pharmaceuticals Co., Ltd.	$6.0B	94	STRONG BUY
1530.HK	3SBio Inc.	$5.9B	96	STRONG BUY
300009.SZ	Anhui Anke Biotechnology (Group) Co., Ltd.	$2.1B	86	STRONG BUY
3759.HK	Pharmaron Beijing Co., Ltd.	$4.1B	59	HOLD
2269.HK	WuXi Biologics (Cayman) Inc.	$17.6B	87	STRONG BUY
002653.SZ	Haisco Pharmaceutical Group Co., Ltd.	$8.5B	56	HOLD
688278.SS	Xiamen Amoytop Biotech Co., Ltd.	$3.4B	58	HOLD

Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 53.0%

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS) — Stock Score Summary

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS) has a MoatMap StockRank of 79/100 based on Quality (75/100), Value (41/100), and Momentum (50/100) factor scores. The current signal is BUY. Sunshine Guojian is a Chinese biopharmaceutical firm focused on antibody drugs. While it has decent quality metrics, it is primarily a drug developer rather than a global CDMO gatekeeper, exposing it to high clinical trial and domestic regulatory risks.

Key Financial Metrics

Price	$8.15
Market Cap	$5.9B
P/E (TTM)	11.70
P/E (Forward)	46.40
Price/Book	4.03
Return on Equity	41.8%
Return on Invested Capital	39.0%
Gross Margin	92.1%
Operating Margin	44.0%
Revenue Growth	38.6%
Dividend Yield	0.8%
Free Cash Flow	$-14M

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd’s (688336.SS) StockRank?: MoatMap’s StockRank for Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS) is 79/100, with a Buy signal. It is a composite of Quality (75), Value (41), and Momentum (50) factor ranks across MoatMap’s 19,000+ stock universe.
Does Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd have an economic moat?: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS) has a Quality factor score of 75/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd a buy, hold, or sell?: MoatMap’s current signal for Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS) is Buy, based on a StockRank of 79/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd in?: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS) operates in the Healthcare sector, specifically the Biotechnology industry (China).